Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 5)*
|
Liberty Star Uranium & Metals Corp. (Name of Issuer) |
Common Stock (Title of Class of Securities) |
53123T305 (CUSIP Number) |
Peter O'Heeron 2 E. Congress St. Ste 900, Tucson, AZ, 85701 281-961-0481 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
03/04/2025 (Date of Event Which Requires Filing of This Statement) |
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
| CUSIP No. | 53123T305 |
| 1 |
Name of reporting person
Peter O'Heeron | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
146,709,838.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
79 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person:
The aggregate number of common securities is 146,709,838. It is a percentage of issued and outstanding of 79%. Current issued and outstanding shares are 86,743,909 plus 100,000,000 (Class A voting power) for 186,743,909. The share count includes 1,957,829 Options & 13,489,280 warrants which are all exercisable within 60 days and so included in the total, plus 500,000 Common Class A shares with voting power of 200 times each share for 100,000,000 for a total voting ownership of 146,709,838.
SCHEDULE 13D
|
| Item 1. | Security and Issuer |
| (a) | Title of Class of Securities:
Common Stock |
| (b) | Name of Issuer:
Liberty Star Uranium & Metals Corp. |
| (c) | Address of Issuer's Principal Executive Offices:
2 East Congress Street, Suite 900, Tucson,
ARIZONA
, 85701. |
| Item 2. | Identity and Background |
| (a) | Peter O'Heeron |
| (b) | 2 E. Congress St. Ste. 900, Tucson, AZ 85701 |
| (c) | FibroBiologics, CEO 455 E. MEDICAL CENTER BLVD., SUITE 300, Houston, TX 77598 |
| (d) | None |
| (e) | None |
| (f) | United States |
| Item 3. | Source and Amount of Funds or Other Consideration |
Personal funds | |
| Item 4. | Purpose of Transaction |
Investment |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|